They worked for me
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation
Semaglutide and liraglutide may reduce alcohol consumption in individuals with AUD owenhaskins Nov 14, 2024 2 min read A joint study by the University of Eastern Finland and Karolinska Institutet in Sweden has found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, were associated with fewer hospitalisations among individuals with alcohol use disorder (AUD)
Research Observation: A 2025 review specifically examined its effect on GLP-1 and insulin secretion, identifying the bacterium's capacity to stimulate GLP-1 production as a key mechanism
Its not unique to this new class of drugs
Diabetic neuropathy relief: strong evidence Alpha-lipoic acid (ALA) is one of the most well-researched supplements for diabetic peripheral neuropathy, a common complication of diabetes that can lead to nerve pain, tingling, numbness, and weakness in the limbs.19 Several clinical trials, particularly those involving intravenous ALA, have shown that doses of 600mg per day can reduce these symptoms over a matter of weeks.20 21 ALAs proposed benefit lies in its antioxidant activity
